Gabriel Shirima

Prof. Dr. Gabriel Shirima

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2021 in Viruses
Verified
Journal Article
Open access
PDF file
ENEmma Njau
Emma Njau
Eunice M. MachukaEunice M. Machuka
Eunice M. Machuka
SCSarah Cleaveland
Sarah Cleaveland
GSGabriel Shirima
Gabriel Shirima
LKLughano J. Kusiluka
Lughano J. Kusiluka
RPRoger Pelle
Roger Pelle
African swine fever (ASF) is a highly infectious and fatal haemorrhagic disease of pigs that is caused by a complex DNA virus of the genus Asfivirus and Asfarviridae African suids family. The disease is among the most devastating pig diseases worldwide including Africa. Although the disease was first reported in the 19th century, it has continued to spread in Africa and other parts of the world. Globally, the rising demand for pork and concomitant increase in transboundary movements of pigs and pork products is likely to increase the risk of transmission and spread of ASF and pose a major challenge to the pig industry. Different genotypes of the ASF virus (ASFV) with varying virulence have been associated with different outbreaks in several countries in sub-Saharan Africa (SSA) and worldwide, and understanding genotype circulation will be important for ASF prevention and control strategies. ASFV genotypes unique to Africa have also been reported in SSA. This review briefly recounts the biology, genomics and genotyping of ASFV and provides an account of the different genotypes circulating in SSA. The review also highlights prevention, control and progress on vaccine development and identifies gaps in knowledge of ASFV genotype circulation in SSA that need to be addressed.

14 September 2020 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
OAOlubunmi R. Aminu
Olubunmi R. Aminu
TLTiziana Lembo
Tiziana Lembo
RZRuth N. Zadoks
Ruth N. Zadoks
RBRoman Biek
Roman Biek
SLSuzanna Lewis
Suzanna Lewis
TFTaya L. Forde
Taya L. Forde
Anthrax threatens human and animal health, and people’s livelihoods in many rural communities in Africa and Asia. In these areas, anthrax surveillance is challenged by a lack of tools for on-site detection. Furthermore, cultural practices and infrastructure may affect sample availability and quality. Practical yet accurate diagnostic solutions are greatly needed to quantify anthrax impacts. We validated microscopic and molecular methods for the detection of Bacillus anthracis in field-collected blood smears and identified alternative samples suitable for anthrax confirmation in the absence of blood smears. We investigated livestock mortalities suspected to be caused by anthrax in northern Tanzania. Field-prepared blood smears (n = 152) were tested by microscopy using four staining techniques as well as polymerase chain reaction (PCR) followed by Bayesian latent class analysis. Median sensitivity (91%, CI 95% [84–96%]) and specificity (99%, CI 95% [96–100%]) of microscopy using azure B were comparable to those of the recommended standard, polychrome methylene blue, PMB (92%, CI 95% [84–97%] and 98%, CI 95% [95–100%], respectively), but azure B is more available and convenient. Other commonly-used stains performed poorly. Blood smears could be obtained for <50% of suspected anthrax cases due to local customs and conditions. However, PCR on DNA extracts from skin, which was almost always available, had high sensitivity and specificity (95%, CI 95% [90–98%] and 95%, CI 95% [87–99%], respectively), even after extended storage at ambient temperature. Azure B microscopy represents an accurate diagnostic test for animal anthrax that can be performed with basic laboratory infrastructure and in the field. When blood smears are unavailable, PCR using skin tissues provides a valuable alternative for confirmation. Our findings lead to a practical diagnostic approach for anthrax in low-resource settings that can support surveillance and control efforts for anthrax-endemic countries globally. Anthrax, an ancient disease largely controlled in the developed world, is still widespread in remote and rural communities of low- and middle-income countries where it affects human and animal health, and livelihoods. To control anthrax effectively, detection and accurate confirmation are important, but solutions need to be feasible for the most-affected areas where resources and infrastructure are typically limited. To achieve this, we assessed a newly proposed stain, azure B, for microscopic confirmation on animal blood smears, as this method can be implemented in low-resource laboratories and in the field. Microscopy using azure B was highly accurate compared to other recommended stains and has the added advantage of being more readily available and convenient. However, blood smear samples were unavailable for more than half of suspected cases. We therefore evaluated a molecular test (PCR) on other sample types–whole blood, blood swabs, skin, and flies–stored at ambient temperature. We show high performance of PCR with skin tissues which were available for 90% of carcasses. Thus, under field conditions, smear samples (when available) and tissue samples are most suitable for diagnostic testing of animal anthrax, whereby microscopy can be conducted in affected areas and PCR in in-country reference laboratories.

24 August 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
RBRebecca F. Bodenham
Rebecca F. Bodenham
SMStella Mazeri
Stella Mazeri
SCSarah Cleaveland
Sarah Cleaveland
JCJohn A. Crump
John A. Crump
Folorunso O. FasinaFolorunso O. Fasina
Folorunso O. Fasina
JHJo Halliday
Jo Halliday
Background: Brucellosis is a neglected zoonosis endemic in many countries, including regions of sub-Saharan Africa. Evaluated diagnostic tools for the detection of exposure to Brucella spp. are important for disease surveillance and guiding prevention and control activities. Methods and findings: Bayesian latent class analysis was used to evaluate performance of the Rose Bengal plate test (RBT) and a competitive ELISA (cELISA) in detecting Brucella spp. exposure at the individual animal-level for cattle, sheep, and goats in Tanzania. Median posterior estimates of RBT sensitivity were: 0.779 (95% Bayesian credibility interval (BCI): 0.570–0.894), 0.893 (0.636–0.989), and 0.807 (0.575–0.966), and for cELISA were: 0.623 (0.443–0.790), 0.409 (0.241–0.644), and 0.561 (0.376–0.713), for cattle, sheep, and goats, respectively. Sensitivity BCIs were wide, with the widest for cELISA in sheep. RBT and cELISA median posterior estimates of specificity were high across species models: RBT ranged between 0.989 (0.980–0.998) and 0.995 (0.985–0.999), and cELISA between 0.984 (0.974–0.995) and 0.996 (0.988–1). Each species model generated seroprevalence estimates for two livestock subpopulations, pastoralist and non-pastoralist. Pastoralist seroprevalence estimates were: 0.063 (0.045–0.090), 0.033 (0.018–0.049), and 0.051 (0.034–0.076), for cattle, sheep, and goats, respectively. Non-pastoralist seroprevalence estimates were below 0.01 for all species models. Series and parallel diagnostic approaches were evaluated. Parallel outperformed a series approach. Median posterior estimates for parallel testing were ≥0.920 (0.760–0.986) for sensitivity and ≥0.973 (0.955–0.992) for specificity, for all species models. Conclusions: Our findings indicate that Brucella spp. surveillance in Tanzania using RBT and cELISA in parallel at the animal-level would give high test performance. There is a need to evaluate strategies for implementing parallel testing at the herd- and flock-level. Our findings can assist in generating robust Brucella spp. exposure estimates for livestock in Tanzania and wider sub-Saharan Africa. The adoption of locally evaluated robust diagnostic tests in setting-specific surveillance is an important step towards brucellosis prevention and control.

1 August 2018 in Vaccine
Verified
Journal Article
Open access
ARAshley Railey
Ashley Railey
TLTiziana Lembo
Tiziana Lembo
GPGuy H. Palmer
Guy H. Palmer
GSGabriel Shirima
Gabriel Shirima
TMThomas Marsh
Thomas Marsh
Identifying the drivers of vaccine adoption decisions under varying levels of perceived disease risk and benefit provides insight into what can limit or enhance vaccination uptake. To address the relationship of perceived benefit relative to temporal and spatial risk, we surveyed 432 pastoralist households in northern Tanzania on vaccination for foot-and-mouth disease (FMD). Unlike human health vaccination decisions where beliefs regarding adverse, personal health effects factor heavily into perceived risk, decisions for animal vaccination focus disproportionately on dynamic risks to animal productivity. We extended a commonly used stated preference survey methodology, willingness to pay, to elicit responses for a routine vaccination strategy applied biannually and an emergency strategy applied in reaction to spatially variable, hypothetical outbreaks. Our results show that households place a higher value on vaccination as perceived risk and household capacity to cope with resource constraints increase, but that the episodic and unpredictable spatial and temporal spread of FMD contributes to increased levels of uncertainty regarding the benefit of vaccination. In addition, concerns regarding the performance of the vaccine underlie decisions for both routine and emergency vaccination, indicating a need for within community messaging and documentation of the household and population level benefits of FMD vaccination.

15 February 2018 in Onderstepoort Journal of Veterinary Research
Verified
Journal Article
Open access
PDF file
SKSusan D. Kerfua
Susan D. Kerfua
GSGabriel Shirima
Gabriel Shirima
LKLughano Kusiluka
Lughano Kusiluka
CAChrisostome Ayebazibwe
Chrisostome Ayebazibwe
RMRobert Mwebe
Robert Mwebe
DHDaniel Haydon
Daniel Haydon
Foot-and-mouth disease (FMD) is one of the major trans-boundary animal diseases in East Africa causing economic loss to farmers and other stakeholders in the livestock industry. Foot-and-mouth disease occurs widely in both Uganda and Tanzania with annual outbreaks recorded. With the recent introduction of the Progressive Control Pathway for FMD control (PCP-FMD) in eastern Africa, knowledge of the spatial and temporal distribution of FMD at the border area between Uganda and Tanzania is helpful in framing engagement with the initial stages of the PCP. Retrospective data collected between 2011 and 2016 from four districts located along the border areas of Uganda and Tanzania, recorded 23 and 59 FMD outbreaks, respectively, for the entire study period. Analysis showed that 46% of the 82 recorded outbreaks occurred in 20% of sub-counties and wards immediately neighbouring the Uganda–Tanzania border and 69.5% of the outbreaks occurred during the dry months. While the serotypes of the FMD virus responsible for most outbreaks reported in this region were not known, previous research reported South African Territory (SAT) 1, SAT 2 and O to be the serotypes in circulation. The results from this study provide evidence of the endemic status of FMD on the Uganda–Tanzania border and emphasise that the border area should be given due consideration during FMD control drives and that cross-border coordination should be prioritised. With the limited data on circulating serotypes in this area, there is a need for more vigilance on FMD case detection, laboratory diagnostic confirmation and provision of more complete documentation of outbreaks. This work further recommends more studies on cross-border livestock movement coupled with phylogenetics in order to understand the spread of the FMD in the border area.

30 June 2010 in Tanzania Journal of Health Research
Verified
Journal Article
Open access
GSGabriel Shirima
Gabriel Shirima
JFJ. M. Fitzpatrick
J. M. Fitzpatrick
JKJ. S. Kunda
J. S. Kunda
GMG. S. Mfinanga
G. S. Mfinanga
RKR. R. Kazwala
R. R. Kazwala
SCSarah Cleaveland
Sarah Cleaveland
The Role of Livestock Keeping in Human Brucellosis Trends in Livestock Keeping Communities in Tanzania